View in EDS

P-31 Real-world efficacy and safety of trifluridine/tipiracil plus bevacizumab for patients with metastatic colorectal cancer refractory to standard therapies.

Saved in:
Bibliographic Details
Title: P-31 Real-world efficacy and safety of trifluridine/tipiracil plus bevacizumab for patients with metastatic colorectal cancer refractory to standard therapies.
Authors: Martínez Lago, N.1, Alonso de Castro, B.2, Varela Ponte, R.3, Reboredo Rendo, C.2, Gomez-Randulfe Rodriguez, M.2, Graña Suarez, B.4, de la cámara gomez, J.2, Mateos Salvador, M.2, Busto Fernandez, F.2, Calleja Chucla, T.2, Reboredo-Lopez, M.2
Source: Annals of Oncology. 2021 Supplement 3, Vol. 32, pS106-S107. 2p.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1016/j.annonc.2021.05.086